Risk Assessment for High-Grade Prostate Cancer Using a Novel Cancer-Specific Biomarker Assay Derived From Autoantibody Signatures

Biomedical Research and Clinical Practice
doi 10.15761/brcp.1000146
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Access Text Pvt, Ltd.

Related search

MA23.03 Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Novel Approach to Biomarker Discovery in Head and Neck Cancer Using an Autoantibody Signature

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification

Diagnostics
Clinical Biochemistry
2018English

Cell-Free DNA: A Novel Biomarker for Patients With Prostate Cancer?

The Open Prostate Cancer Journal
2010English

High Grade Prostatic Intraepithelial Neoplasia and the Risk of Prostate Cancer

Open Journal of Urology
2018English

The Novel Prostate Cancer Antigen 3 (PCA3) Biomarker

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2010English

Prostate-Specific Antigen (PSA) Assay for Early Detection of Prostate Cancer Recurrence

Science-Business eXchange
2009English

Autoantibody Signatures: Progress and Perspectives for Early Cancer Detection

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2011English

Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer

Anticancer Research
MedicineCancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy